{"id":5248,"date":"2024-12-11T17:22:31","date_gmt":"2024-12-11T16:22:31","guid":{"rendered":"https:\/\/irccs.com\/patologie\/endometriosis\/"},"modified":"2026-03-25T16:11:10","modified_gmt":"2026-03-25T15:11:10","slug":"endometriosis","status":"publish","type":"pathology","link":"https:\/\/irccs.com\/en\/patologie\/endometriosis\/","title":{"rendered":"Endometriosis"},"content":{"rendered":"\n

<\/span>Pathology<\/h2>\n\n\n\n

Endometriosis is a widespread<\/strong> condition (affecting about one in 10 women<\/strong>), characterized by the presence of the tissue that normally lines the inside of the uterus (endometrium) outside the uterine cavity itself.<\/p>\n\n\n\n

Endometriosis is a multifactorial<\/strong> and hormone-dependent<\/strong> condition typical of childbearing age. It generally has a chronic, progressive<\/strong> course with possible recurrence<\/strong>, and manifests mainly with pelvic pain<\/strong> and difficulty in conception(infertility<\/strong>).<\/p>\n\n\n\n

The most common sites where endometriosis implants<\/strong> develop are the ovaries<\/strong>, the pelvic peritoneum<\/strong> (the membrane that lines the pelvis internally), and the recto-vaginal septum<\/strong> (the space between the rectum and vagina). However, this disease can also affect other organs and tissues of the body, with the exception of the spleen<\/strong>.<\/p>\n\n\n\n

Endometriosis is also associated with an increased risk of some gynecologic cancers<\/strong>, including ovarian carcinoma, endometrial carcinoma, and sarcomas of the endometrial stroma. Indeed, studies have shown that women with endometriosis have a 3- to 5-fold higher<\/strong> risk of developing ovarian cancer than the general population. In numbers, ovarian cancer<\/a> is observed in 1.5 percent of women with endometriosis<\/strong>, compared with 0.04 percent in the general population<\/strong>. At the same time, endometriosis is more common among women with ovarian cancer, with an incidence of 8% to 30%.<\/p>\n\n\n\n

At the Candiolo Institute, we treat this disease with a specific approach that allows us to accurately recognize precancerous forms <\/strong>and intervene early on those that could develop into cancer.
The goal is to offer patients a safe and effective course of care<\/strong>, thanks to advanced expertise that allows for gentle and targeted treatments similar to gynecologic oncology surgery, but with a less invasive approach.<\/p>\n\n\n\n

Clinical divisions involved<\/h3>\n\n\n\n

The diagnostic and therapeutic pathway of endometriosis at Candiolo involves several clinical divisions, including the Gynecologic Oncology<\/a><\/strong> and the Ovarian Cancer Center<\/a><\/strong>.<\/p>\n\n\n\n

<\/span>Symptoms<\/strong><\/h2>\n\n\n\n

The most common symptoms are:<\/p>\n\n\n\n